Skip to Main Content

Author Details

Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
1995
62
16
PMIDPaper TitleJournal TitlePublished Year
36831546CD8+ Cell Density Gradient across the Tumor Epithelium-Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy.Cancers (Basel)2023
37614027Combination of DNA methylation biomarkers with multiparametric magnetic resonance and ultrasound imaging fusion biopsy to detect the local spread of prostate cancer.Prostate2023
36979741Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients.Biomedicines2023
37109639Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies.Medicina (Kaunas)2023
34689221Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma.J Cancer Res Clin Oncol2022
35630084Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury.Medicina (Kaunas)2022
34970742Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study.Prostate2022
33435132Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.Medicina (Kaunas)2021
33488712LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer.J Oncol2021
34675538Clinical Significance of <i>ADAMTS19, BMP7, SIM1</i>, and <i>SFRP1</i> Promoter Methylation in Renal Clear Cell Carcinoma.Onco Targets Ther2021
34442004Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients.J Clin Med2021
34198725Promoter Methylation of <i>PRKCB</i>, <i>ADAMTS12</i>, and <i>NAALAD2</i> Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.Int J Mol Sci2021
32343215Reply by Authors.J Urol2020
32033148The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival.Medicina (Kaunas)2020
32068491Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.J Urol2020
32775459Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection.Biomed Res Int2020
32577094Partial nephrectomy can be a successful treatment option for renal epithelioid angiomyolipoma: a case report and literature review.Acta Med Litu2020
32873304Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?J Transl Med2020
32249545Fiber attenuated total reflection infrared spectroscopy of kidney tissue during live surgery.J Biophotonics2020
31002354DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma.Oncol Rep2019
31383039Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.Clin Epigenetics2019
31014272Prostate cancer solitary metastasis to anal canal: case report and review of literature.BMC Cancer2019
29316381Rapid intra-operative diagnosis of kidney cancer by attenuated total reflection infrared spectroscopy of tissue smears.J Biophotonics2018
29928155Malignant mixed epithelial and stromal tumour of the kidney: a case report and a literature review.Acta Med Litu2018
29732208Bosniak category III renal lesions: likelihood of malignancy based on computed tomography findings.Cent European J Urol2018
28977898Decreased expression of <i>MT1E</i> is a potential biomarker of prostate cancer progression.Oncotarget2017
28398479Clinical significance of miRNA host gene promoter methylation in prostate cancer.Hum Mol Genet2017
27490805The utility of urine-circulating miRNAs for detection of prostate cancer.Br J Cancer2016
27170485Detection of miRNAs in urine of prostate cancer patients.Medicina (Kaunas)2016
25369892Heterogeneity of DNA methylation in multifocal prostate cancer.Virchows Arch2015
26459268Frequent down-regulation of ABC transporter genes in prostate cancer.BMC Cancer2015
23365006Non-linear optical microscopy of kidney tumours.J Biophotonics2014
25223375Malignancy after renal transplantation: a single-center experience.Ann Transplant2014
24980613Prognostic value of RASSF1 promoter methylation in prostate cancer.J Urol2014
25097693Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques.Wideochir Inne Tech Maloinwazyjne2014
25140885Identification of kidney tumor tissue by infrared spectroscopy of extracellular matrix.J Biomed Opt2014
23429795Combined studies of chemical composition of urine sediments and kidney stones by means of infrared microspectroscopy.J Biomed Opt2013
24048440Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damage.Ann Transplant2013
23645761Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies.Anticancer Res2013
22619380Epigenetic markers of prostate cancer in plasma circulating DNA.Hum Mol Genet2012
22505341Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.Genes Chromosomes Cancer2012
21378359Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2.Anticancer Res2011
21822036Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.Medicina (Kaunas)2011
21950920Infrared spectroscopic imaging of renal tumor tissue.J Biomed Opt2011
19924441Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.J Cancer Res Clin Oncol2010
20679745The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.Medicina (Kaunas)2010
20610281Considerations on implementing diagnostic markers into clinical decision making in bladder cancer.Urol Oncol2010
19623534Extremely low risk of pheochromocytomas in complete VHL gene deletion cases.Hum Mutat2009
18824877Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.Oncology2008
16699974Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma.Invest New Drugs2006
  • 1 - 50 of 62

Recommended Authors

Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 3
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 1
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 1
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 4
Seok-Soo Byun
Seoul National University Bundang Hospital
Career Start Year 2002
Number of shared co-authors 0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 1
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 3
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 2
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 3
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 6
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 2
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 2
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 1
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 3
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 4
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 3
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 1
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 1
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 4
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 6
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Sonata Jarmalaite
Institute of Biosciences, Vilnius University
Co-authored papers 25
Arvydas Laurinavicius
Vilnius University
Co-authored papers 10
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 2
Justina Tverkuviene
Co-authored papers 1
Andrew Kwan
University of Toronto
Co-authored papers 1
Ying Wu
Co-authored papers 1
Arturas Petronis
The Campbell Family Mental Health Research Institute
Co-authored papers 1
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Juozas Gordevi??ius
Epigenetic Clock Development Foundation
Co-authored papers 1
Syed Haider
Institute of Cancer Research
Co-authored papers 1
Olga E Bryzgunova
Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences
Co-authored papers 1
Anna A Bondar
Institute of Chemical Biology and Fundamental Medicine SB RAS
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Rene Cortese
Child Health Research Institute, University of Missouri
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Emilie Lalonde
University of Pennsylvania
Co-authored papers 1
Pavel P Laktionov
Institute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences
Co-authored papers 1
Mina Park
College of Medicine, The Catholic University of Korea
Co-authored papers 1
Gabriel Oh
The Campbell Family Mental Health Research Institute
Co-authored papers 1
Steve van Os
Co-authored papers 1
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 1
Sun-Chong Wang
National Central University
Co-authored papers 1
Zachary A Kaminsky
Institute of Mental Health Research, University of Ottawa
Co-authored papers 1
Release 1.2